These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 27640246)

  • 21. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
    Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
    Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
    Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
    Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets.
    Arafat B; Wojsz M; Isreb A; Forbes RT; Isreb M; Ahmed W; Arafat T; Alhnan MA
    Eur J Pharm Sci; 2018 Jun; 118():191-199. PubMed ID: 29559404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and characterization of a novel 3D printed pressure-controlled drug delivery system.
    Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W
    Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug.
    Kempin W; Domsta V; Grathoff G; Brecht I; Semmling B; Tillmann S; Weitschies W; Seidlitz A
    Pharm Res; 2018 Apr; 35(6):124. PubMed ID: 29679157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.
    Scoutaris N; Ross SA; Douroumis D
    Pharm Res; 2018 Jan; 35(2):34. PubMed ID: 29368113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
    Bhatt U; Malakar TK; Murty US; Banerjee S
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
    Than YM; Titapiwatanakun V
    Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
    Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
    Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA
    Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
    Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA
    Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.
    Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW
    Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
    Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
    Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
    Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
    Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
    Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
    Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hot melt extrusion paired fused deposition modeling 3D printing to develop hydroxypropyl cellulose based floating tablets of cinnarizine.
    Vo AQ; Zhang J; Nyavanandi D; Bandari S; Repka MA
    Carbohydr Polym; 2020 Oct; 246():116519. PubMed ID: 32747229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
    Chung S; Zhang P; Repka MA
    Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.